• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Characterisation and haemagglutinin gene epitope mapping of a variant strain of H5N1 subtype avian influenza virus

tetano

Editor, Senior Moderator
Vet Microbiol. 2012 Nov 29. pii: S0378-1135(12)00666-9. doi: 10.1016/j.vetmic.2012.11.033. [Epub ahead of print]
Characterisation and haemagglutinin gene epitope mapping of a variant strain of H5N1 subtype avian influenza virus.
Li Y, Zhang X, Xu Q, Fu Q, Zhu Y, Chen S, Peng D, Liu X.
Source

College of Veterinary Medicine, Ministry of Education Key Lab for Avian Preventive Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, PR China.
Abstract

H5N1 avian influenza virus (AIV) undergoes rapid evolution, and its antigenicity needs to be constantly evaluated in order to update the vaccine strain. In this report, a clade 7.2 AIV isolate named A/Chicken/Huadong/4/2008 (DT) is identified. Antigenic analysis revealed that DT had a significant low cross-reactive HI titre with antiserum against a clade 7 representative AIV, A/Chicken/Shanxi/2/2006 (Re-4). Animal experiments demonstrated that the Re-4+Re-5 vaccine provided 80% protection against DT challenge in chickens. Antisera cross-reactivity showed that a mutant with a change of residues 129, 139, 140 in site A in the HA protein had reduced reactivity with DT antiserum and increased reactivity with Re-4 antiserum. Furthermore, residue Leu129 in site A of the HA protein was confirmed to be critical for maintenance of the reactivity with the DT antiserum, and Asn140, possessing a new glycosylation site, was confirmed to be critical for reducing reactivity with the Re-4 antiserum. These results imply that there is an antigenic drift within clade 7 viruses, and insertion and glycosylation of amino acid residues in site A of the HA protein may contribute to the antigenic variation.

Copyright ? 2012 Elsevier B.V. All rights reserved.

PMID:
23265247
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23265247
 
Back
Top Bottom